本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Revolution Medicines, Inc.

37.44
-2.3550-5.92%
盤後37.440.00000.00%19:54 EDT
成交量:308.93萬
成交額:1.16億
市值:69.61億
市盈率:-10.47
高:39.60
開:39.33
低:36.36
收:39.80
資料載入中...
2021/03/08

重要事件披露

8-K - Current report
2021/03/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/01

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]